Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33,940,151
-
Total 13F shares
-
20,661,150
-
Share change
-
+743,132
-
Total reported value
-
$556,198,812
-
Put/Call ratio
-
58%
-
Price per share
-
$26.94
-
Number of holders
-
105
-
Value change
-
+$24,043,989
-
Number of buys
-
49
-
Number of sells
-
56
Institutional Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q1 2022
As of 31 Mar 2022,
TransMedics Group, Inc. - Common Stock (TMDX) was held by
105 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,661,150 shares.
The largest 10 holders included
FMR LLC, MACQUARIE GROUP LTD, Sandhill Capital Partners LLC, BlackRock Inc., CREDIT SUISSE AG/, VANGUARD GROUP INC, STATE STREET CORP, Bank of New York Mellon Corp, Bellevue Group AG, and KORNITZER CAPITAL MANAGEMENT INC /KS.
This page lists
105
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.